
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Azelis Group
Market Cap: €2.6b
Engages in the distribution and sale of specialty chemicals and food ingredients.
AZE
€10.98
7D
-2.1%
1Y
-41.8%
Kinepolis Group
Market Cap: €811.8m
Operates and manages cinemas in Belgium, France, Canada, Spain, the Netherlands, the United States, Luxembourg, and internationally.
KIN
€30.35
7D
-2.1%
1Y
-22.1%
Ion Beam Applications
Market Cap: €323.7m
Designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally.
IBAB
€11.06
7D
-1.8%
1Y
-20.2%
Deceuninck
Market Cap: €282.0m
Engages in the design, manufacture, recycling, and distribution of multi-material window, door, and building solutions in Europe, North America, Turkey, and internationally.
DECB
€2.04
7D
-0.2%
1Y
-15.0%
Immobel
Market Cap: €244.9m
Engages in the real estate development business in Belgium, France, Luxembourg, Germany, Poland, Spain, and the United Kingdom.
IMMO
€23.95
7D
4.1%
1Y
22.2%
Onward Medical
Market Cap: €198.9m
A medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI).
ONWD
€4.45
7D
-13.6%
1Y
-9.0%
Nyxoah
Market Cap: €180.6m
A medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA).
NYXH
€4.83
7D
-4.5%
1Y
-47.0%
Atenor
Market Cap: €172.4m
Operates as a real estate development company in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, Britain, and Romania.
ATEB
€2.84
7D
-5.6%
1Y
-35.2%
Biotalys
Market Cap: €163.6m
An agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally.
BTLS
€4.36
7D
1.9%
1Y
37.1%
Hyloris Pharmaceuticals
Market Cap: €151.2m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.40
7D
-4.9%
1Y
-7.8%
Agfa-Gevaert
Market Cap: €131.0m
Develops, manufactures, and markets various analog and digital systems worldwide.
AGFB
€0.85
7D
-0.4%
1Y
-16.2%
Sequana Medical
Market Cap: €44.9m
Develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally.
SEQUA
€0.74
7D
-4.9%
1Y
-23.4%
Belysse Group
Market Cap: €33.2m
Manufactures and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally.
BELYS
€0.93
7D
-4.6%
1Y
9.5%